Template-dependent DNA ligation for the synthesis of modified oligonucleotides

Marcel Hollenstein,Nazarii Sabat,Andreas Stämpfli,Serena Bisagni,Filippo Sladojevich,Kurt Püntener,Steven Hanlon
DOI: https://doi.org/10.26434/chemrxiv-2023-vwwt5-v2
2024-03-27
Abstract:Chemical modification of DNA is a common strategy to improve the properties of oligonucleotides, particularly for therapeutics and nanotechnology. Existing synthetic methods essentially rely on phosphoramidite chemistry or the polymerization of nucleoside triphosphates but are limited in terms of size, scalability, and sustainability. Herein, we report a robust alternative method for the de novo synthesis of modified oligonucleotides using template-dependent DNA ligation of shortmer fragments. Our approach is based on the fast and scaled accessibility of chemically modified shortmer monophosphates as substrates for the T3 DNA ligase. This method has shown high tolerance to chemical modifications, flexibility and overall efficiency, thereby granting access to an ultimately broad range of modified oligonucleotides of different lengths (20 → 120 nucleotides). We have applied this method to the synthesis of clinically relevant antisense drugs and diversely modified ultramers. Furthermore, the designed chemoenzymatic approach has great potential for diverse applications in therapeutics and biotechnology.
Chemistry
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to propose a new method for synthesizing chemically modified oligonucleotides, particularly for therapeutic applications and the biotechnology field. The currently used synthesis methods (such as the phosphoramidite method or nucleotide triphosphate polymerization) have some limitations, such as deficiencies in size, scalability, and sustainability. To address these issues, the authors developed a new method based on a template-dependent DNA ligase reaction, synthesizing modified oligonucleotides of different lengths by joining short fragments (shortmers). Specifically, this method leverages the high tolerance of T3 DNA ligase to chemical modifications and can efficiently synthesize oligonucleotides ranging from 20 to 120 nucleotides. Additionally, this method has been applied to synthesize clinically relevant antisense drugs and various modified ultramers. In summary, this method offers high efficiency, flexibility, and broad application potential in the synthesis of chemically modified oligonucleotides.